Form 4: Guardant Health Director Myrtle S. Potter Reports Stock Transaction
SEC Form 4 Filing
Director Myrtle S. Potter reports a transaction involving Guardant Health, Inc. common stock and restricted stock units.
Summary
- On April 15, 2025, Myrtle S. Potter, a director of Guardant Health, Inc., reported a transaction.
- The transaction involved the vesting of 68 restricted stock units, which converted into 68 shares of common stock.
- Following the transaction, Potter directly owns 411 derivative securities.
Sentiment
Score: 5
Explanation: This is a neutral report on stock transactions by a company director. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This is a standard SEC filing related to insider trading. It is a routine disclosure and doesn't necessarily indicate a significant event for the company.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it involves a small number of shares.
Key Dates
| Date | Description |
|---|---|
| October 15, 2022 | 25% of the restricted stock units vested. |
| April 15, 2025 | Transaction date: 68 restricted stock units vested and converted to common stock. |
| April 16, 2025 | Date of signature for the report. |
Keywords
Form 4, Guardant Health, Director, Stock Transaction, Myrtle S. Potter, Restricted Stock Units, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.